Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

PROSHARES TRUST (ZBIO) Shares Outstanding (Weighted Average): 2023-2024

Historic Shares Outstanding (Weighted Average) for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to $41.8 million.

  • Zenas BioPharma's Shares Outstanding (Weighted Average) rose 0.76% to $42.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.1 million, marking a year-over-year increase of 0.76%. This contributed to the annual value of $41.8 million for FY2024, which is 57.36% up from last year.
  • According to the latest figures from FY2024, Zenas BioPharma's Shares Outstanding (Weighted Average) is $41.8 million, which was up 57.36% from $26.6 million recorded in FY2023.
  • Zenas BioPharma's Shares Outstanding (Weighted Average)'s 5-year high stood at $41.8 million during FY2024, with a 5-year trough of $26.6 million in FY2023.
  • In the last 2 years, Zenas BioPharma's Shares Outstanding (Weighted Average) had a median value of $34.2 million in 2023 and averaged $34.2 million.
  • Data for Zenas BioPharma's Shares Outstanding (Weighted Average) shows a peak YoY spiked of 57.36% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Zenas BioPharma's Shares Outstanding (Weighted Average) stood at $26.6 million in 2023, then skyrocketed by 57.36% to $41.8 million in 2024.